Cytotoxic activity of gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukemia correlates with the expression of protein kinase Syk
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/2404437.pdf
Reference42 articles.
1. Griffin JD, Linch D, Sabbath K, Larcom P, Schlossman SF . A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leukemia Res 1984; 8: 521–527.
2. Sievers EL, Appelbaum FR, Spielberger RT . Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamycin immunoconjugate. Blood 1999; 93: 3678–3684.
3. Freeman SD, Kelm S, Barber EK, Crocker PR . Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 1995; 85: 2005–2012.
4. Ulyanova T, Blasioli J, Woodford-Thomas TA, Thomas ML . The sialoadhesin CD33 is a myeloid-specific inhibitory receptor. Eur J Immunol 1999; 29: 3440–3449.
5. Taylor VC, Buckley CD, Douglas M, Cody AJ, Simmons DL, Freeman SD . The myeloid-specific scialic acid-binding receptor, CD33, associates with the protein tyrosine phosphatases, SHP-1 and SHP-2. J Biol Chem 1999; 274: 11505–11512.
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Spleen tyrosine kinase (SYK): an emerging target for the assemblage of small molecule antitumor agents;Expert Opinion on Investigational Drugs;2024-08-11
2. Biological therapy in elderly patients with acute myeloid leukemia;Expert Opinion on Biological Therapy;2023-02-01
3. Use of CD122+ natural killer cell precursors for superior anti-leukemia responses;2022-10-24
4. Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy;Frontiers in Immunology;2022-10-04
5. Gemtuzumab ozogamicin (GO) as monotherapy and in combination with hypomethylation agents in the treatment of acute myeloid leukemia: a systematic meta-analysis;Hematology;2022-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3